ES2152304T3 - Procedimiento para el crecimiento del virus del sindrome reproductivo y respiratorio porcino y su uso en vacunas. - Google Patents

Procedimiento para el crecimiento del virus del sindrome reproductivo y respiratorio porcino y su uso en vacunas.

Info

Publication number
ES2152304T3
ES2152304T3 ES94907895T ES94907895T ES2152304T3 ES 2152304 T3 ES2152304 T3 ES 2152304T3 ES 94907895 T ES94907895 T ES 94907895T ES 94907895 T ES94907895 T ES 94907895T ES 2152304 T3 ES2152304 T3 ES 2152304T3
Authority
ES
Spain
Prior art keywords
virus
vaccines
growth
procedure
reproductive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94907895T
Other languages
English (en)
Inventor
Thomas Sanderson
Michael J Mcginley
Jeffrey J Zimmerman
Howard T Hill
Michael C Meetz
Eugene C Pirtle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Bayer Corp
Iowa State University Research Foundation Inc ISURF
Original Assignee
Bayer AG
Bayer Corp
Iowa State University Research Foundation Inc ISURF
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG, Bayer Corp, Iowa State University Research Foundation Inc ISURF filed Critical Bayer AG
Application granted granted Critical
Publication of ES2152304T3 publication Critical patent/ES2152304T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/815—Viral vaccine for porcine species, e.g. swine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)

Abstract

UN PROCESO PARA DESARROLLAR UN PRRSV EN UN CULTIVO DE TEJIDO QUE SEA SUSCEPTIBLE DE INFECCION PARA REPRODUCIR EXACTAMENTE EL VIRUS EN UNA CANTIDAD SUFICIENTE PARA PROTEGER LOS ANIMALES CONTRA PRRS O SER USADA PARA DIAGNOSTICAR PRRS O IDENTIFICAR LA ESTRUCTURA MOLECULAR DE PRRSV PARA DESARROLLAR PRODUCTOS RECOMBINANTES, QUE COMPRENDEN LA INOCULACION DEL VIRUS EN EL CULTIVO DE TEJIDO Y COSECHAR EL VIRUS REPRODUCIDO.
ES94907895T 1993-02-08 1994-01-26 Procedimiento para el crecimiento del virus del sindrome reproductivo y respiratorio porcino y su uso en vacunas. Expired - Lifetime ES2152304T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1491593A 1993-02-08 1993-02-08

Publications (1)

Publication Number Publication Date
ES2152304T3 true ES2152304T3 (es) 2001-02-01

Family

ID=21768529

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94907895T Expired - Lifetime ES2152304T3 (es) 1993-02-08 1994-01-26 Procedimiento para el crecimiento del virus del sindrome reproductivo y respiratorio porcino y su uso en vacunas.

Country Status (21)

Country Link
US (2) US5510258A (es)
EP (1) EP0683816B1 (es)
JP (1) JP3710095B2 (es)
KR (1) KR100374295B1 (es)
CN (1) CN1080300C (es)
AT (1) ATE197314T1 (es)
AU (1) AU681874B2 (es)
BG (1) BG63170B1 (es)
CZ (1) CZ289743B6 (es)
DE (1) DE69426228T2 (es)
DK (1) DK0683816T3 (es)
ES (1) ES2152304T3 (es)
FI (1) FI117513B (es)
GR (1) GR3035257T3 (es)
HU (1) HU218430B (es)
NO (1) NO317662B1 (es)
NZ (1) NZ261992A (es)
PL (1) PL178609B1 (es)
PT (1) PT683816E (es)
SK (1) SK98695A3 (es)
WO (1) WO1994018311A1 (es)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3128133B2 (ja) * 1991-06-06 2001-01-29 スティッチティング セントラール ディールゲネースクンディグ インスティトゥート 豚の奇病の原因体であるレリスタドエイジェント、それを含むワクチン組成物、豚の奇病の診断キット及び診断方法
US5846805A (en) 1991-08-26 1998-12-08 Boehringer Ingelheim Animal Health, Inc. Culture of swine infertility and respiratory syndrome virus in simian cells
US6042830A (en) * 1992-08-05 2000-03-28 Boehringer Ingelheim Vetmedica, Inc. Viral agent associated with mystery swine disease
US6080570A (en) * 1991-08-26 2000-06-27 Boehringer Ingelheim Vetmedica, Inc. Method of producing a vaccine for Swine Infertility and Respiratory Syndrome
US6982160B2 (en) * 1991-08-26 2006-01-03 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions that include SIRS virus
US6592873B1 (en) 1992-10-30 2003-07-15 Iowa State University Research Foundation, Inc. Polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus (PRRSV) and proteins encoded by the polynucleic acids
US5695766A (en) * 1992-10-30 1997-12-09 Iowa State University Research Foundation Highly virulent porcine reproductive and respiratory syndrome viruses which produce lesions in pigs and vaccines that protect pigs against said syndrome
US6380376B1 (en) 1992-10-30 2002-04-30 Iowa State University Research Foundation Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (PRRSV)
US6773908B1 (en) 1992-10-30 2004-08-10 Iowa State University Research Foundation, Inc. Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (PRRSV)
ES2074950B1 (es) * 1993-09-17 1996-03-16 Iberica Cyanamid Vacuna para la prevencion de la enfermedad reproductiva y respiratoria de la cerda.
US5690940A (en) * 1995-06-21 1997-11-25 Regents Of The University Of Minnesota Low pathogencity PRRS live virus vaccines and methods of preparation thereof
ES2102971B1 (es) 1996-01-25 1998-03-01 Hipra Lab Sa Nueva cepa atenuada del virus causante del sindrome respiratorio y reproductivo porcino (prrs), las vacunas y medios de diagnostico obtenibles con la misma y los procedimientos para su obtencion.
AU2277497A (en) * 1996-03-01 1997-09-16 Schering Corporation Porcine reproductive and respiratory syndrome vaccine
US5866401A (en) * 1996-03-01 1999-02-02 Schering Corporation Porcine reproductive and respiratory syndrome vaccine
US6015663A (en) * 1996-03-01 2000-01-18 The United States Of America As Represented By The Secretary Of Agriculture Restriction enzyme screen for differentiating porcine reproductive and respiratory syndrome virus strains
US5976537A (en) * 1996-07-02 1999-11-02 The United States Of America As Represented By The Secretary Of Agriculture Porcine reproductive and respiratory syndrome vaccine
FR2751224B1 (fr) * 1996-07-19 1998-11-20 Rhone Merieux Formule de vaccin polynucleotidique contre les pathologies respiratoires et de reproduction des porcs
DK0835930T3 (da) * 1996-10-09 2001-06-18 Akzo Nobel Nv Europæiske vaccinestammer af porcint reproduktions- og respirationssyndrom-virus. (PRRSV)
US20040224327A1 (en) * 1996-10-30 2004-11-11 Meulenberg Johanna Jacoba Maria Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof
EP0839912A1 (en) * 1996-10-30 1998-05-06 Instituut Voor Dierhouderij En Diergezondheid (Id-Dlo) Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof
WO1998035023A1 (en) * 1997-02-07 1998-08-13 Origen, Inc. Method for growing porcine reproductive and respiratory syndrome virus for use as vaccines and diagnostic assays
CZ297371B6 (cs) 1997-05-06 2006-11-15 Boehringer Ingelheim Vetmedica Gmbh Peptid mající 5 az 15 aminokyselinových zbytku vyvolávající tvorbu protilátek, protilátka reaktivnís tímto peptidem a diagnostická testovací souprava
AU8393398A (en) * 1997-07-10 1999-02-08 Regents Of The University Of Minnesota Causative agent of sow abortion and mortality syndrome (sams), vaccine compositions, antibodies and method
UA78180C2 (uk) 1997-10-03 2007-03-15 Меріаль Кільцевий вірус свині типу ii, вакцини та діагностичні реагенти
FR2772047B1 (fr) 1997-12-05 2004-04-09 Ct Nat D Etudes Veterinaires E Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection
NZ513289A (en) 1998-12-22 2003-04-29 Pfizer Prod Inc Infectious cDNA clone of north american procine reproductive and respiratory syndrome (PRRS) virus and uses thereof
EP1157121B1 (en) 1999-03-08 2013-04-24 Boehringer Ingelheim Vetmedica GmbH Prrsv replicon
ES2388909T3 (es) 1999-04-22 2012-10-19 The United States Of America, As Represented Bythe Secretary Of Agriculture Vacuna contra el virus del síndrome respiratorio y reproductivo porcino basada en aislado JA-142 aislada
US6497883B1 (en) * 1999-06-10 2002-12-24 Merial Porcine circovirus recombinant poxvirus vaccine
ES2170622B1 (es) * 1999-12-03 2004-05-16 Consejo Superior De Investigaciones Cientificas Clones y vectores infectivos derivados de coronavirus y sus aplicaciones.
WO2001046390A2 (en) * 1999-12-20 2001-06-28 Agricultural Research Council Method of inactivating microorganisms
ES2267719T3 (es) * 2000-02-08 2007-03-16 Regents Of The University Of Minnesota Virus del sindrome reproductivo y respiratorio porcino y metodos de empleo.
US6740490B2 (en) * 2001-01-29 2004-05-25 Kansas State University Research Foundation Identification and applications of porcine reproductive and respiratory syndrome virus host susceptibility factor(s) for improved swine breeding
US6841364B2 (en) * 2002-01-22 2005-01-11 Protatek International, Inc. Infectious cDNA clones of porcine reproductive and respiratory syndrome virus and expression vectors thereof
US7906311B2 (en) 2002-03-20 2011-03-15 Merial Limited Cotton rat lung cells for virus culture
RU2219946C1 (ru) * 2002-04-25 2003-12-27 Федеральное государственное учреждение Всероссийский научно-исследовательский институт защиты животных Вирусвакцина против репродуктивно-респираторного синдрома свиней
RU2220202C1 (ru) * 2002-04-25 2003-12-27 Федеральное государственное учреждение Всероссийский научно-исследовательский институт защиты животных Штамм "бд" вируса репродуктивно-респираторного синдрома свиней для изготовления диагностических и вакцинных препаратов
RU2232596C1 (ru) * 2002-10-16 2004-07-20 Федеральное государственное учреждение Всероссийский научно-исследовательский институт защиты животных Способ изготовления вирус-вакцины против репродуктивно-респираторного синдрома свиней
SG153829A1 (en) 2004-06-18 2009-07-29 Univ Minnesota Identifying virally infected and vaccinated organisms
US7632636B2 (en) 2004-09-21 2009-12-15 Boehringer Ingelheim Vetmedica, Inc. Porcine reproductive and respiratory syndrome isolates and methods of use
PT2281829E (pt) 2004-12-30 2015-02-18 Boehringer Ingelheim Vetmed Composições imunogénicas de pcv2 para utilização num método de prevenção de infecção de pcv2
US7691368B2 (en) 2005-04-15 2010-04-06 Merial Limited Vaccine formulations
PT2369001T (pt) 2005-06-24 2016-10-25 Univ Minnesota Vírus srrp, clones infecciosos, os seus mutantes e processos de utilização
US20080226669A1 (en) 2005-12-29 2008-09-18 Boehringer Ingelheim Vetmedica, Inc. Multivalent pcv2 immunogenic compositions and methods of producing such compositions
CN100523177C (zh) * 2007-01-09 2009-08-05 中国农业科学院哈尔滨兽医研究所 猪繁殖与呼吸综合症病毒弱毒疫苗株及其应用
WO2008089094A2 (en) * 2007-01-12 2008-07-24 The Board Of Trustees Of The University Of Illinois Non-simian cells for growth of porcine reproductive and respiratory syndrome (prrs) virus
US7666585B2 (en) * 2007-06-15 2010-02-23 Protatek International, Inc. Construction of chimera PRRSV, compositions and vaccine preparations
CN101848995A (zh) * 2007-06-25 2010-09-29 南达科他州立大学 重组的北美1型猪繁殖与呼吸综合征病毒及使用方法
FI122778B (fi) 2008-03-31 2012-06-29 Metso Power Oy Pyrolyysimenetelmä kattilan yhteydessä ja pyrolyysilaitteisto
CN101363865B (zh) * 2008-05-26 2013-03-06 北京庄笛浩禾生物医学科技有限公司 一种猪蓝耳病毒胶体金检测试纸条、其制备方法及其应用
KR101653177B1 (ko) * 2008-08-25 2016-09-01 베링거잉겔하임베트메디카인코퍼레이티드 고병원성 돼지 생식기 및 호흡기 증후군(ｈｐ ｐｒｒｓ)에 대한 백신
TWI627281B (zh) 2009-09-02 2018-06-21 百靈佳殷格翰家畜藥品公司 降低ｐｃｖ－２組合物殺病毒活性之方法及具有改良免疫原性之ｐｃｖ－２組合物
US9107859B2 (en) 2009-09-10 2015-08-18 Merial, Inc. Vaccine formulations comprising saponin-containing adjuvants
SG192821A1 (en) 2011-02-17 2013-09-30 Boehringer Ingelheim Vetmed Commercial scale process for production of prrsv
EP2675475B1 (en) 2011-02-17 2015-07-01 Boehringer Ingelheim Vetmedica GmbH Novel european prrsv strain
EP2737059A1 (en) 2011-07-29 2014-06-04 Boehringer Ingelheim Vetmedica GmbH Novel prrs virus inducing type i interferon in susceptible cells
US9187731B2 (en) 2011-07-29 2015-11-17 Boehringer Ingelheim Vetmedica Gmbh PRRS virus inducing type I interferon in susceptible cells
CA2844927C (en) 2011-08-12 2017-10-31 Merial Limited Vacuum-assisted preservation of biological products, in particular of vaccines
MX366051B (es) 2012-12-07 2019-06-26 Univ Illinois Composiciones del virus del síndrome reproductor y respiratorio de porcino y sus usos.
US9579373B2 (en) 2013-03-15 2017-02-28 Boehringer Ingelheim Vetmedica, Inc. Porcine reproductive and respiratory syndrome virus, compositions, vaccine and methods of use
EP3049106A1 (en) 2013-09-25 2016-08-03 Zoetis Services LLC Pcv2b divergent vaccine composition and methods of use
TWI745278B (zh) 2014-10-10 2021-11-11 以色列商艾畢克生物實驗有限公司 發泡性降低之疫苗組合物
CN104694485A (zh) * 2015-02-13 2015-06-10 广西壮族自治区兽医研究所 Z-ietd-fmk在提高prrsv体外培养滴度方面的应用及其方法
DK3471760T3 (da) 2016-06-17 2025-01-27 Boehringer Ingelheim Vetmedica Gmbh Hidtil ukendte immunogene formuleringer, der omfatter lineære eller forgrenede polyacrylsyrepolymeradjuvanser

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5213795A (en) * 1990-10-24 1993-05-25 Oxford Encephalomyocarditis virus vaccine
JP3128133B2 (ja) * 1991-06-06 2001-01-29 スティッチティング セントラール ディールゲネースクンディグ インスティトゥート 豚の奇病の原因体であるレリスタドエイジェント、それを含むワクチン組成物、豚の奇病の診断キット及び診断方法
KR0138092B1 (ko) * 1991-08-26 1998-04-30 제임스 씨. 데세사레 미확인(Mystery) 돼지 질병 관련 바이러스제
DE69214657T4 (de) * 1991-08-26 2003-07-17 Boehringer Ingelheim Vetmed Vakzine gegen und diagnosemethode für das schweine-unfruchtbarkeits- und atmungs-syndrom (suas)
AU2696792A (en) * 1991-09-16 1993-04-27 David A Benfield Vaccine for mystery swine disease and method for diagnosis thereof
ES2083764T5 (es) * 1991-10-14 2009-04-01 Intervet International Bv Vacuna para el sindrome respiratorio reproductivo porcino (srrp) y diagnostico.
FR2682966B1 (fr) * 1991-10-29 1994-12-02 Rhone Merieux Preparation d'antigenes et de vaccins du virus de la mystery disease, antigenes et vaccins obtenus pour la prevention de cette maladie.
US5695766A (en) * 1992-10-30 1997-12-09 Iowa State University Research Foundation Highly virulent porcine reproductive and respiratory syndrome viruses which produce lesions in pigs and vaccines that protect pigs against said syndrome

Also Published As

Publication number Publication date
SK98695A3 (en) 1996-11-06
DE69426228D1 (de) 2000-12-07
DK0683816T3 (da) 2001-01-08
HU9502330D0 (en) 1996-05-28
CZ203195A3 (en) 1995-12-13
US5510258A (en) 1996-04-23
KR100374295B1 (ko) 2003-12-24
ATE197314T1 (de) 2000-11-15
AU681874B2 (en) 1997-09-11
HU218430B (hu) 2000-08-28
FI117513B (fi) 2006-11-15
FI953731L (fi) 1995-08-04
NZ261992A (en) 1996-06-25
NO953091L (no) 1995-08-07
BG63170B1 (bg) 2001-05-31
GR3035257T3 (en) 2001-04-30
CZ289743B6 (cs) 2002-03-13
DE69426228T2 (de) 2001-03-01
US5587164A (en) 1996-12-24
PL310126A1 (en) 1995-11-27
JPH08506486A (ja) 1996-07-16
CN1117742A (zh) 1996-02-28
JP3710095B2 (ja) 2005-10-26
NO317662B1 (no) 2004-11-29
EP0683816B1 (en) 2000-11-02
BG99850A (bg) 1996-02-28
AU6128594A (en) 1994-08-29
FI953731A0 (fi) 1995-08-04
PL178609B1 (pl) 2000-05-31
CN1080300C (zh) 2002-03-06
EP0683816A1 (en) 1995-11-29
WO1994018311A1 (en) 1994-08-18
HUT72917A (en) 1996-06-28
PT683816E (pt) 2001-03-30
NO953091D0 (no) 1995-08-07

Similar Documents

Publication Publication Date Title
ES2152304T3 (es) Procedimiento para el crecimiento del virus del sindrome reproductivo y respiratorio porcino y su uso en vacunas.
Wiktor Cell-mediated immunity and postexposure protection from rabies by inactivated vaccines of tissue culture origin
SE8104661L (sv) Stabil mikrokristallin form av cisplatin, forfarande for framstellning derav samt stabil, steril torrblandningsberedning derav
AU2684792A (en) Porcine reproductive respiratory syndrome vaccine and diagnostic
DE59207852D1 (de) Peroral applizierbare arzneiform zur behandlung zentraler dopaminmangelzustände
AR006023A1 (es) Vacuna contra el sindrome reproductivo y respiratorio porcino
DK0666751T3 (da) Mutanter af hepatitis A-virus, stamme HM-175, til anvendelse som hepatitis A-vacciner
ES442892A1 (es) Un procedimiento para la produccion de una vacuna que cuandose inyecta en gatos es capaz de inmunizarlos contra el feli-ne calicivirus.
ES498752A0 (es) Un procedimiento para preparar una vacuna de virus vivos de la peritonitis infecciosa de los felinos
ATE133073T1 (de) Verwendung gegen reaktive sauerstoffverbindungen schützender wirkstoffe
DK0833903T3 (da) Multivalent vaccine mod bovint coronavirus og fremgangsmåde til behandling af infektioner forårsaget af bovint coronavirus
NL300073I1 (nl) Vaccin.
Bolton et al. Note on obtaining virus-free plants of red raspberry through the use of tip cuttings
Kuhlman Temperature, inoculum type, and leaf maturity affect urediospore production by Cronartium Quercuum F. sp. fusiforme
ES471766A1 (es) Un procedimiento de preparacion de un virus vivo atenuado dela para-influenza
RU2219946C1 (ru) Вирусвакцина против репродуктивно-респираторного синдрома свиней
CA2155533A1 (en) Process for growing porcine reproductive and respiratory syndrome virus and its use in vaccines
RU94031386A (ru) Вакцина сухая культуральная против вирусного энтерита гусей и способ профилактики и лечения вирусного энтерита гусей
David-West Propagation and plaquing of Dugbe virus (an ungrouped Nigerian arbovirus) in various mammalian and arthropod cell lines
AR023643A1 (es) Formulaciones de vacuna de multiples antigenos
GB839876A (en) A process for the preparation of a vaccine containing live attenuated infectious canine hepatitis virus
FR2404438A1 (fr) Procede de desinfection, debacterisation, sterilisation, desinsectisation a l'oxyde d'ethylene, et appareillage pour la mise en oeuvre de ce procede
RU94030087A (ru) Способ получения вакцины против болезни гамборо
KR950031107A (ko) 돼지 생식기 호흡기 증후군(prrs)병의 불활화 및 생독백신 제조방법
Roca et al. Virus inhibition and clone propagation in cassava

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 683816

Country of ref document: ES